News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
Presentation TCT 2018 TCT-110: Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry Presenter: George D. Dangas, Germano Di Sciascio, Kamilia Moalem September 21, 2018
Presentation TCT 2018 Does Aspirin Have a Role in the Management of Patients Undergoing PCI? Presenter: Jeroen J. Bax, Stephan Windecker, Patrick W. Serruys September 21, 2018
Presentation TCT 2018 Atrial Fibrillation and ACS/PCI: The End of Triple Therapy? Presenter: Jeroen J. Bax, Stephan Windecker September 21, 2018
Presentation TCT 2017 SENIOR and Shorter DAPT Studies: Highlights Summary Presenter: Martin B. Leon, Marco Valgimigli, Olivier Varenne November 01, 2017
Presentation TCT 2017 COMPASS Trial: Topline Findings and Practice Implications Presenter: Robert A. Harrington, Evan A. Stein, Michelle O'Donoghue November 01, 2017
Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx November 01, 2017
Presentation TCT 2017 FOURIER Trial: Topline Findings and Practice Implications Presenter: Robert A. Harrington, Evan A. Stein, Wolfgang Koenig November 01, 2017
Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes November 01, 2017
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice? Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz November 01, 2017
Presentation TCT 2017 When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy? Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran November 01, 2017
Presentation TCT 2017 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: Robert A. Harrington, Kurt Huber, Michelle O'Donoghue November 01, 2017
Presentation TCT 2017 Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More Presenter: Robert A. Harrington, Kurt Huber, Didier Carrié November 01, 2017
News Conference News TCT 2017 Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES Todd Neale November 01, 2017
Presentation TCT 2017 What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt November 01, 2017
Presentation TCT 2017 Optimizing the Acute and Chronic Use of Antiplatelet and Antithrombotic Agents (and Their Combination): 2017 Update Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Dimitrios Alexopoulos November 01, 2017
Presentation TCT 2017 REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata November 01, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017